中国医药 (600056.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(中国医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年三季报2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报
主要指标:
 营业收入(元) 26,099,729,998.4017,797,322,228.738,774,845,924.5738,824,430,504.8529,796,767,468.5021,624,971,226.5412,530,663,199.18
 营业利润(元) 850,564,674.59606,652,720.96275,532,249.931,672,334,222.651,105,488,870.09873,142,857.99406,844,907.96
 利润总额(元) 842,783,779.00604,023,833.45273,566,147.941,640,555,520.801,109,150,508.67874,300,636.47406,610,349.26
 净利润(元) 620,917,976.67449,756,770.46202,880,820.281,242,120,464.96783,662,782.78676,753,330.14320,582,342.33
 归属于母公司股东的净利润(元) 447,148,326.32325,119,038.69145,599,951.991,048,039,144.39594,110,580.95543,547,678.43268,770,140.93
盈利能力:
 销售毛利率(%) 10.6610.9110.3011.2911.0811.129.84
 销售净利率(%) 2.382.532.313.202.633.132.56
 净资产收益率(%) 3.912.861.28----
 总资产报酬率ROA(%) 2.551.800.83----
 投入资本回报率ROIC(%) 2.421.760.795.913.423.091.53
营运能力:
 存货周转率(次) 3.392.421.16----
 应收账款周转率(次) 1.691.130.57----
 总资产周转率(次) 0.690.460.23----
偿债能力:
 资产负债率(%) 62.8062.8762.3562.8864.1565.4365.05
 股东权益比率(%) 30.7830.7531.2830.9029.3028.2328.71
 已获利息倍数(倍) 7.617.817.2615.6417.5037.6610.40
 流动比率 1.451.491.541.581.531.531.55
 速动比率 1.041.121.151.181.111.111.08
发展能力:
 营业收入增长率(%) -12.41-17.70-29.973.2810.7022.5147.08
 营业利润增长率(%) -23.06-30.52-32.2839.40-10.03-9.136.51
 税后利润增长率(%) -24.74-40.19-45.8342.47-22.51-11.769.27
 净资产增长率(%) 4.183.865.626.903.324.315.53
 总资产增长率(%) -0.81-4.66-3.074.2114.1023.9319.49

前瞻产业研究院